Access the full text.
Sign up today, get DeepDyve free for 14 days.
Dusmet (2004)
Surgery for small cell lung cancerHematol Oncol Clin North Am, 18
W. Fox, J. Scadding (1973)
Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.Lancet, 2 7820
K. Hotta, K. Matsuo, H. Ueoka, K. Kiura, M. Tabata, M. Tanimoto (2004)
Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 19
T. Lad, S. Piantadosi, P. Thomas, D. Payne, J. Ruckdeschel, G. Giaccone (1994)
A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.Chest, 106 6 Suppl
F. Shepherd, R. Ginsberg, R. Haddad, R. Feld, U. Sagman, W. Evans, G. Deboer, E. Maki (1993)
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 8
L. Sobin, Thomas Aquinas (1987)
TNM Classification of Malignant Tumours
F. Shepherd, R. Ginsberg, R. Feld, W. Evans, Else Johansen (1991)
Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.The Journal of thoracic and cardiovascular surgery, 101 3
M. Gould, W. Kuschner, C. Rydzak, Courtney Maclean, Anita Demas, H. Shigemitsu, J. Chan, D. Owens (2003)
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.Annals of internal medicine, 139 11
E. Lim, Yoong Yap, B. Stavola, A. Nicholson, P. Goldstraw (2005)
The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors.The Journal of thoracic and cardiovascular surgery, 130 4
J. Deslauriers (1997)
Surgery for small cell lung cancer.Lung cancer, 17 Suppl 1
P. Jänne, B. Freidlin, S. Saxman, David Johnson, R. Livingston, F. Shepherd, B. Johnson (2002)
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North AmericaCancer, 95
M. Gould, Courtney Maclean, W. Kuschner, C. Rydzak, D. Owens (2001)
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.JAMA, 285 7
Ch. Wittekind, M. Gospodarowicz, L. Sobin (2009)
TNM Classification of Malignant Tumours, 7th Edition
R. Govindan, N. Page, D. Morgensztern, W. Read, R. Tierney, A. Vlahiotis, E. Spitznagel, J. Piccirillo (2006)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 28
P. Goldstraw (1997)
Report on the international workshop on intrathoracic staging. London, October 1996Lung Cancer, 18
ORIGINAL ARTICLE The Role of Surgery in the Treatment of Limited Disease Small Cell Lung Cancer Time to Reevaluate Eric Lim, FRCS (C-Th), Elizabeth Belcher, FRCS, Yoon Khoong Yap, MRCS, Andrew G. Nicholson, FRCPath, and Peter Goldstraw, FRCS trials reported a current median survival of 17 months and Abstract: Chemo-radiation is considered the standard procedure for data from the Surveillance, Epidemiological and End Results the management of limited disease small-cell lung cancer (SCLC). program of the National Cancer Institute (Bethesda, Mary- Controversy remains as to when surgery should be considered. We land) reported an overall 5 year survival of 10%. sought to determine the survival after complete resection of SCLC Surgery has been considered unsuitable for patients and the prognostic impact of clinical and pathologic stage. with limited stage disease as it had been associated with Methods: A retrospective review was undertaken of patients who overall 5 year survival of less than 5%. Early randomized underwent surgery between 1980 and 2006. Patients were staged trials comparing surgery alone versus radiotherapy reported according to the 6th edition of the Tumor, Node, Metastasis classifica- 4% survival at 2-years in patients randomized to surgery tion of lung cancer, actuarial survival estimated with
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Nov 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.